Skip to main content
PROTIA INC. logo

PROTIA INC. — Investor Relations & Filings

Ticker · 303360 ISIN · KR7303360002 KO Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2020-07-24 Director's Dealing
Country KR South Korea
Listing KO 303360

About PROTIA INC.

https://www.protia.co.kr/en/main

PROTIA INC. is an in-vitro diagnostics (IVD) company that develops, manufactures, and sells a wide range of diagnostic kits and instruments. The company is particularly known for its flagship product, PROTIA Allergy-Q, a multiplex allergy diagnostic kit for the quantitative determination of allergen-specific IgE. Its portfolio also includes point-of-care testing (POCT) solutions like the ImmuneCheck IgG kit, diagnostic tests for infectious and autoimmune diseases, cancer, and antibiotic susceptibility, as well as the ANITIA line for companion animal allergy testing. In addition to its product offerings, PROTIA provides comprehensive protein analysis services, including LC-MS/MS and characterization analysis, aiming to contribute to early disease prediction and diagnosis through innovative technology.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (South Korea). This document details the shareholding changes of a specific executive (Jung Myung-sook) of ProteomeTech. In the context of financial filings, reports regarding personal share transactions by company directors and executives are classified as 'Director's Dealing'.
2020-07-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an insider (director or major shareholder) changes their shareholding position. Based on the provided categories, this falls under 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2020-07-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. This document details the shareholding changes of an executive (Choi Dong-sub) of ProteomeTech. In the context of financial filings, reports detailing personal share transactions by company directors and executives are classified as 'Director's Dealing'.
2020-07-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders to disclose their shareholdings and changes therein. This falls under the 'Director's Dealing' category, as it reports personal share transactions or changes in ownership by company directors and executives.
2020-07-24 Korean
권리락(무상증자)
Share Issue/Capital Change Classification · 1% confidence The document is a short announcement regarding a 'rights off' (권리락) event due to a bonus issue (무상증자) for the company ProteomeTech. It provides specific details such as the reference price and the effective date. This type of corporate action announcement regarding capital changes fits the 'Share Issue/Capital Change' category.
2020-07-20 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) from ProteomeTech regarding a 'Bonus Issue' (무상증자결정). This is a formal regulatory filing detailing a change in capital structure through the issuance of new shares to existing shareholders. According to the provided definitions, announcements regarding new share issues, stock splits, or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2020-07-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.